Sarah Hill
Anatomic Pathology · Boston, MANPI 1912357138
Payments from drug & device makers
What this record shows
This record is dominated by grants: $54,000 of the $54,394 with a category attached, or 99.3%. AstraZeneca accounts for 99.3% of it on its own, with 1 other manufacturer making up the rest. Among anatomic pathology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 2 payments — averaging $27,197 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$54K
- Eli Lilly$394
Across 8 payments — averaging $125,847 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$533K
- Merck$380K
- Astrazeneca UK Limited$93K
What the payments were for
- Grants$54,00099%
- Travel & lodging$3941%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 1 | $54,000 |
| Eli Lilly | 1 | $394 |
How this compares
$54,394 in reported general payments places this provider in the 95th percentile of 119 anatomic pathology providers in Massachusetts.
Other anatomic pathology in Boston
- Mari Mino KenudsonBoston$143K
- Hatice GurBoston$112K
- Keith LigonBoston$88K
- Robert ColvinBoston$46K
- Lauren Ritterhouse CasariegoBoston$39K
- Gregory LauwersBoston$27K
- Robert PaderaBoston$22K
- Frederick SchoenBoston$21K
- Andrew BeckBoston$17K
- Kenneth LeeBoston$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.